title: Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.
abstract: The important role of activating killer immunoglobulin-like receptors (KIRs) in protecting against cytomegalovirus (CMV) reactivation has been described previously in patients undergoing hematopoietic cell transplantation (HCT). More specifically, the presence of multiple activating KIRs and the presence of at least KIR2DS2 and KIR2DS4 in the donor genotype identified a group of HCT patients at low risk for CMV reactivation. However, CMV infection still occurs in patients with the KIR protective genotype, and the question has been raised as to whether this is related to the lack of KIR expression. In this report, expression of the KIR2DS2 and KIR2DS4 genes, as measured by mRNA-based quantitative polymerase chain reaction in both the donor cells and the HCT recipient cells, was studied relative to CMV reactivation. In the control samples from healthy donors, the median range for KIR2DS2 and KIR2DS4 expression was low, with 35% of donors considered null-expressers. Interestingly, KIR2DS2 and KIR2DS4 expression was elevated after HCT compared with donor expression before HCT, and was significantly elevated in CMV viremic compared with CMV nonviremic HCT recipients. The CMV seropositivity of donors was not associated with activating KIR expression, and donor null expression in those with the KIR2DS2 or KIR2DS4 genotype was not predictive for CMV reactivation in the recipient. After controlling for other transplant factors, including donor type (sibling or unrelated), transplant source (bone marrow or peripheral blood stem cells), and acute GVHD grade, regression analysis of elevated KIR gene expression found an association for both KIR2DS2 and KIR2DS4, with a 7-fold increase in risk for CMV reactivation. We speculate that the elevated activating KIR expression in CMV-viremic HCT recipients is either coincidental with factors that activate CMV or is initiated by CMV or cellular processes responsive to such CMV infection reactivation.
authors: CMV Laboratory, Department of Virology, City of Hope, 1500 E Duarte Road, Duarte, CA 91010, USA.
authors: Ghislaine M
authors: GM
authors: Gallez-Hawkins
authors: Anne E
authors: AE
authors: Franck
authors: Xiuli
authors: X
authors: Li
authors: Lia
authors: L
authors: Thao
authors: Arisa
authors: A
authors: Oki
authors: Ketevan
authors: K
authors: Gendzekhadze
authors: Andrew
authors: A
authors: Dagis
authors: Joycelynne
authors: J
authors: Palmer
authors: Ryotaro
authors: R
authors: Nakamura
authors: Stephen J
authors: SJ
authors: Forman
authors: David
authors: D
authors: Senitzer
authors: John A
authors: JA
authors: Zaia
references: J Clin Oncol. 2009 Apr 1;27(10):1644-52
references: 19224849
references: J Exp Med. 2010 Sep 27;207(10):2065-72
references: 20819928
references: J Clin Microbiol. 1985 Feb;21(2):217-21
references: 2982911
references: Am J Transplant. 2008 Jun;8(6):1312-7
references: 18444913
references: J Exp Med. 2010 Sep 27;207(10):2073-9
references: 20819924
references: Biol Blood Marrow Transplant. 2005 Nov;11(11):890-902
references: 16275592
references: Immunity. 1997 Dec;7(6):753-63
references: 9430221
references: Blood. 2006 Feb 1;107(3):1230-2
references: 16239436
references: Curr Top Microbiol Immunol. 2006;298:207-23
references: 16323417
references: Transplantation. 2006 Oct 27;82(8):1024-30
references: 17060849
references: Tissue Antigens. 2004 Oct;64(4):462-8
references: 15361123
references: Br J Haematol. 1994 Jul;87(3):609-13
references: 7527648
references: Bone Marrow Transplant. 2008 Dec;42(11):723-31
references: 18711352
references: Bone Marrow Transplant. 2006 Sep;38(6):437-44
references: 16892071
references: Clin Immunol. 2009 Feb;130(2):213-24
references: 18945643
references: J Exp Med. 2010 Sep 27;207(10):2049-52
references: 20876314
references: Blood. 2007 Jul 15;110(2):578-86
references: 17392508
references: Leukemia. 2005 Aug;19(8):1446-51
references: 15973456
references: Annu Rev Immunol. 2005;23:225-74
references: 15771571
references: Blood. 2004 Feb 15;103(4):1521-6
references: 14504099
references: Biol Blood Marrow Transplant. 2009 Mar;15(3):315-25
references: 19203722
references: J Immunol. 2002 Oct 15;169(8):4253-61
references: 12370356
references: J Immunol. 2005 Nov 1;175(9):5966-74
references: 16237090
references: J Exp Med. 2009 Oct 26;206(11):2557-72
references: 19858347
references: Tissue Antigens. 2007 Apr;69 Suppl 1:123-4
references: 17445184
references: Blood. 2009 Oct 15;114(16):3422-30
references: 19628706
references: Immunogenetics. 2002 Nov;54(8):543-50
references: 12439616
references: J Immunol. 2010 Aug 15;185(4):2009-12
references: 20631304
references: J Immunol. 2005 May 15;174(10):6540-5
references: 15879158